• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer.使用直肠癌术前放化疗的临床参数预测肿瘤反应。
World J Gastroenterol. 2011 Dec 28;17(48):5310-6. doi: 10.3748/wjg.v17.i48.5310.
2
Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.动态对比增强磁共振成像:用于预测局部晚期直肠癌新辅助放化疗后的病理完全缓解情况
J Magn Reson Imaging. 2015 Sep;42(3):673-80. doi: 10.1002/jmri.24835. Epub 2015 Feb 5.
3
A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer.多基因模型预测直肠癌术前放化疗后肿瘤的反应性。
Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):834-842. doi: 10.1016/j.ijrobp.2019.07.058. Epub 2019 Aug 13.
4
Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.扩散加权磁共振成像和磁共振容积测量法——用于评估局部晚期直肠癌患者术前放化疗后的肿瘤反应。
Magn Reson Imaging. 2015 Feb;33(2):201-12. doi: 10.1016/j.mri.2014.08.041. Epub 2014 Nov 13.
5
Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.使用 18FDG-PET/CT 预测局部晚期直肠癌新辅助放化疗的病理反应。
Ann Surg Oncol. 2012 Jul;19(7):2178-85. doi: 10.1245/s10434-012-2248-z. Epub 2012 Mar 7.
6
Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.局部进展期直肠癌新辅助短程放疗或放化疗后延迟手术的病理完全缓解率比较。
Eur J Surg Oncol. 2018 Jul;44(7):1013-1017. doi: 10.1016/j.ejso.2018.03.014. Epub 2018 Mar 23.
7
Carbohydrate antigen 19-9 levels associated with pathological responses to preoperative chemoradiotherapy in rectal cancer.糖类抗原19-9水平与直肠癌术前放化疗的病理反应相关。
Asian Pac J Cancer Prev. 2014;15(13):5383-7. doi: 10.7314/apjcp.2014.15.13.5383.
8
Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.血清癌胚抗原水平变化对局部晚期直肠癌术前放化疗反应的预测价值。
World J Gastroenterol. 2020 Nov 28;26(44):7022-7035. doi: 10.3748/wjg.v26.i44.7022.
9
Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients.预测直肠癌患者对术前放化疗的多类别反应。
Radiat Oncol. 2016 Mar 22;11:50. doi: 10.1186/s13014-016-0623-9.
10
Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.扩散加权成像:表观扩散系数直方图分析用于检测局部晚期直肠癌对放化疗的病理完全缓解
J Magn Reson Imaging. 2016 Jul;44(1):212-20. doi: 10.1002/jmri.25117. Epub 2015 Dec 15.

引用本文的文献

1
Do not expect an endoluminal complete response to identify a pathologic complete response in rectal cancer!不要期望腔内完全缓解能用来判定直肠癌的病理完全缓解!
Clinics (Sao Paulo). 2025 Feb 4;80:100587. doi: 10.1016/j.clinsp.2025.100587. eCollection 2025.
2
Radiomics in rectal cancer: current status of use and advances in research.直肠癌中的放射组学:应用现状与研究进展
Front Oncol. 2025 Jan 17;14:1470824. doi: 10.3389/fonc.2024.1470824. eCollection 2024.
3
Assessing the predictive value of clinical factors to pathological complete response for locally advanced rectal cancer: An analysis of 124 patients.评估临床因素对局部晚期直肠癌病理完全缓解的预测价值:124例患者的分析
Front Oncol. 2023 Mar 31;13:1125470. doi: 10.3389/fonc.2023.1125470. eCollection 2023.
4
Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?基于影像组学方法预测局部晚期直肠癌新辅助治疗后的病理完全缓解:已准备好进入黄金时代了吗?
Cancers (Basel). 2023 Jan 9;15(2):432. doi: 10.3390/cancers15020432.
5
Predicting stage ypT0-1N0 for nonradical management in patients with middle or low rectal cancer who undergo neoadjuvant chemoradiotherapy: a retrospective cohort study.预测接受新辅助放化疗的中低位直肠癌患者非根治性治疗的ypT0-1N0分期:一项回顾性队列研究
Ann Surg Treat Res. 2022 Jul;103(1):32-39. doi: 10.4174/astr.2022.103.1.32. Epub 2022 Jul 7.
6
Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study.基线直肠肿瘤长度与放化疗后磁共振肿瘤退缩分级反应的关系:TRIGGER 可行性研究的亚分析。
Ann Surg Oncol. 2023 Aug;30(8):4729-4735. doi: 10.1245/s10434-022-11914-5. Epub 2022 Jun 30.
7
MRI Evaluation of Complete Response of Locally Advanced Rectal Cancer After Neoadjuvant Therapy: Current Status and Future Trends.新辅助治疗后局部晚期直肠癌完全缓解的MRI评估:现状与未来趋势
Cancer Manag Res. 2021 Jun 1;13:4317-4328. doi: 10.2147/CMAR.S309252. eCollection 2021.
8
Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.新辅助放化疗治疗直肠癌后病理完全缓解的预测因素。
Asian Pac J Cancer Prev. 2021 May 1;22(5):1607-1611. doi: 10.31557/APJCP.2021.22.5.1607.
9
Chondrocyte Deformations Under Mild Dynamic Loading Conditions.软骨细胞在轻度动态加载条件下的形变。
Ann Biomed Eng. 2021 Feb;49(2):846-857. doi: 10.1007/s10439-020-02615-9. Epub 2020 Sep 21.
10
Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy.新辅助放化疗后局部晚期直肠癌患者中,基于FOLFOX方案、长间隔、血红蛋白水平及临床阴性淋巴结状态以及放化疗后癌胚抗原水平对病理完全缓解的预测价值
J Oncol. 2020 Jan 28;2020:9437684. doi: 10.1155/2020/9437684. eCollection 2020.

本文引用的文献

1
Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer.MRI 和 18F-FDG PET/CT 在前瞻性放化疗后直肠癌再分期中的准确性。
World J Surg. 2009 Dec;33(12):2688-94. doi: 10.1007/s00268-009-0248-3.
2
Biomarkers for response to neoadjuvant chemoradiation for rectal cancer.直肠癌新辅助放化疗反应的生物标志物。
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):673-88. doi: 10.1016/j.ijrobp.2009.03.003.
3
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.新辅助治疗后病理完全缓解在局部晚期直肠癌中的预后价值:对566例ypCR患者的长期分析
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):99-107. doi: 10.1016/j.ijrobp.2007.12.019. Epub 2008 Apr 11.
4
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer.预测直肠癌术前放化疗后病理肿瘤反应的临床参数。
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1167-72. doi: 10.1016/j.ijrobp.2007.04.047.
5
Preoperative chemoradiation followed by transanal excision for rectal cancer.术前同步放化疗后行经肛门切除术治疗直肠癌。
J Surg Res. 2008 Aug;148(2):244-50. doi: 10.1016/j.jss.2007.08.010. Epub 2007 Sep 14.
6
Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer.直肠癌新辅助放化疗后的非手术治疗
Lancet Oncol. 2007 Jul;8(7):625-33. doi: 10.1016/S1470-2045(07)70202-4.
7
A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography.与那些根据术前直肠内超声检查未实现肿瘤降期的患者相比,直肠癌对术前综合治疗的病理完全缓解可带来更好的肿瘤学结局。
Ann Surg Oncol. 2006 Aug;13(8):1047-53. doi: 10.1245/ASO.2006.03.053. Epub 2006 Jul 24.
8
Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery.经肛门内镜显微手术前接受放疗的T2-3 N0期低位直肠癌患者的长期结果。
Br J Surg. 2005 Dec;92(12):1546-52. doi: 10.1002/bjs.5178.
9
Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer.接受术前放疗/放化疗后达到完全病理缓解(pT0)的局部晚期或局部复发性直肠癌患者的临床结局。
J Surg Oncol. 2005 Oct 1;92(1):70-5. doi: 10.1002/jso.20340.
10
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point.直肠癌术前放化疗后的临床检查并非可靠的替代终点。
J Clin Oncol. 2005 May 20;23(15):3475-9. doi: 10.1200/JCO.2005.06.114.

使用直肠癌术前放化疗的临床参数预测肿瘤反应。

Predicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer.

机构信息

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Irwon-dong 50, Gangnam-gu, Seoul 135-710, South Korea.

出版信息

World J Gastroenterol. 2011 Dec 28;17(48):5310-6. doi: 10.3748/wjg.v17.i48.5310.

DOI:10.3748/wjg.v17.i48.5310
PMID:22219601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3247696/
Abstract

AIM

To evaluate the clinical parameters and identify a better method of predicting pathological complete response (pCR).

METHODS

We enrolled 249 patients from a database of 544 consecutive rectal cancer patients who underwent surgical resection after preoperative chemoradiation therapy (PCRT). A retrospective review of morphological characteristics was then performed to collect data regarding rectal examination findings. A scoring model to predict pCR was then created. To validate the ability of the scoring model to predict complete regression.

RESULTS

Seventy patients (12.9%) achieved a pCR. A multivariate analysis found that pre-CRT movability (P = 0.024), post-CRT size (P = 0.018), post-CRT morphology (P = 0.023), and gross change (P = 0.009) were independent predictors of pCR. The accuracy of the scoring model was 76.8% for predicting pCR with the threshold set at 4.5. In the validation set, the accuracy was 86.7%.

CONCLUSION

Gross changes and morphological findings are important predictors of pathological response. Accordingly, PCRT response is best predicted by a combination of clinical, laboratory and metabolic information.

摘要

目的

评估临床参数并确定预测病理完全缓解(pCR)的更好方法。

方法

我们从 544 例连续接受术前放化疗(PCRT)后行手术切除的直肠癌患者数据库中纳入 249 例患者。然后回顾性分析形态特征,收集直肠检查结果数据。然后创建预测 pCR 的评分模型。为了验证评分模型预测完全消退的能力。

结果

70 例(12.9%)患者达到 pCR。多变量分析发现,术前 CRT 可移动性(P=0.024)、术后 CRT 大小(P=0.018)、术后 CRT 形态(P=0.023)和大体变化(P=0.009)是 pCR 的独立预测因子。评分模型预测 pCR 的准确率为 76.8%,阈值设定为 4.5。在验证集中,准确率为 86.7%。

结论

大体变化和形态学发现是病理反应的重要预测因子。因此,PCRT 反应最好通过临床、实验室和代谢信息的组合来预测。